The global catheter stabilization devices market size was worth USD 1402.09 Million in 2024. It is further estimated to be growing at a CAGR of 7.44% and worth USD 2007.27 Million by 2029.
Catheter Stabilization Devices secure the position of a catheter on a patient's skin to maintain the catheter’s position inserted through an insertion site. They are commonly used to administer medicines to a patient or to extract body fluids. The device consists of a catheter clipping element that is present on an anti-allergic adhesive pad. The catheter clipping element comprises a clipping body that ends in open arms for convenient and easy clipping and unclipping of a cannula, catheter, catheter, cannula terminal adapter, etc. The clipping body is directed outwards from the surface at the top of the pad in a transverse direction or vertical direction or facilitates unclipping and clipping. A longitudinal axis of the clipping body can be directed towards the top surface of the pad to enhance stabilization and support for the correct orientation of the catheter in the direction of the insertion site.
The global catheter stabilization devices market is expected to be driven by the global prevalence of cardiovascular illnesses and cancer incidences. Chronic lifestyle diseases are on the rise, as are accidental instances, which are being recorded at an alarmingly high rate. These variables include an increase in the number of procedures performed in trauma centers and hospitals, which need a catheter at some time during the procedure. As a result, there is a greater requirement for catheter stability and security. Over the projected period, the market is expected to rise due to the rising demand for minimally invasive surgeries worldwide. Catheter stabilization devices are becoming increasingly important as the need for less invasive treatments grows. However, catheter product recalls prevent hospitals and clinics from quickly adapting to these devices.
Governments' supporting policies to strengthen the healthcare system and economic improvements in growing nations like India and China would propel the Asia Pacific regional market. Hospitalizations among cardiovascular patients are also on the rise, especially in late adulthood and old age, when the patient is suffering from many symptoms at the same time. Companies like Bard, Baxter, and others have created arterial securement devices widely used in hospitals and clinics. These companies have well-developed distribution networks. As a result of these variables, there is a greater need for arterial securement devices, which leads to improved surgical operations. As a result, the clinical stabilization devices market is expected to be dominated over the forecast period.
However, the global catheter stabilization devices market growth is constrained by factors such as alternative devices and the high price of technologically advanced products.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Analysed |
By Product, Application, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
Market Leaders Profiled |
Medtronic plc (U.S.), 3M Company (U.S.), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.S.), C. R. Bard, Inc. (U.S.), Baxter International, Inc. (U.S.), Smiths Group plc (U.K.), Centurion Medical Products (U.S.), Merit Medical Systems, Inc. |
The cardiovascular application segment is forecasted to account for the largest share in the global catheter stabilization devices market during the forecast period. A rising number of heart patients are suffering from heart strokes, valve blockages, and more. In 2017, as per the American Heart Association, 801,000 deaths in the U.S were due to cardiovascular diseases.
The arterial securement devices segment is predicted to lead the global catheter stabilization devices market with a considerable share over the period based on the product. Arterial catheters are used in routine healthcare treatments. The arterial catheters are broadly used in many surgeries performed associated with cancer therapies and cardiovascular diseases.The Central venous catheter (CVC) securement device segment grows faster with the highest CAGR rate during the forecast period. The components tracts important due to the advantages like the non-existence of interruptions during the treatments and CVC replacement costs reduction.
Based on the end-user, the hospital segment dominates the catheter stabilization devices market. The number of surgeries performed, wide usage of catheters in hospitals for various diseases, and expected growth of infections in hospitals contribute a significant share for the segment growth.
Geographically, the North American regional market is expected to dominate the global market during the forecast period. Growing aging people with chronic ailments such as cancer, cardiovascular diseases, and the growing importance of minimally invasive surgeries surge the market growth. The United States is estimated to play a leading role in the North American market. The rising number of catheter placements and the adoption of catheterization techniques in examination, diagnosis, and treatment responsible for the market growth in the region. As per the Joint Commission, an estimation of 300 million catheters used every year in the U.S., of which around 3million are central venous catheters. The Canadian catheter securement devices market is expected to have a healthy growth rate during the forecast period.
The European market is forecasted to have an impressive growth rate from 2022 to 2028. The growing cases of central line-associated bloodstream infection (CLABSI) and the European Medical Agency (EMA) for catheter stabilization devices market. The stipulating healthcare expenses accelerate the market growth. According to the OECD, Germany's healthcare expenses were EUR 321 billion in 2014. The U.K market is expected to lead the catheter stabilization devices in the Europe region. The healthcare organizations are in a state to afford the high cost of the treatment and devices, driving the market growth. Germany is witnessing a tremendous growth rate during the assessment period. Growing government support and huge funds for the introduction of innovative products spurred Germany's market growth. THE SEAT LOCK Foley stabilization device is a strap-free device that locks the Foley catheter and stabilizes the catheter.
Asia-Pacific is the quickest growing region in the catheter stabilization devices market. Growing patient population, high unmet needs, and developed infrastructure are propelling the market's growth rate. Stipulating the requirement for better diagnostic devices, quick improvements in technology, and a better and safe therapeutic approach accelerates market demand. According to ESCAP statistical database, in 2016, around 12.4% of the APAC population was over 60years. China is expected to have a notable growth rate and lead the catheter stabilization devices market. India and Japan are projected to have stabilized market growth. Indian market growth is increasing healthcare investments, creating opportunities for key players to enter the market.
Some of the major players in the global catheter stabilization devices market profiled in the report are Medtronic plc (U.S.), 3M Company (U.S.), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.S.), C. R. Bard, Inc. (U.S.), Baxter International, Inc. (U.S.), Smiths Group plc (U.K.), Centurion Medical Products (U.S.), Merit Medical Systems, Inc. (U.S.) and M.C. Johnson Company, Inc. (U.S.).
This research report on the global catheter stabilization devices market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2029.
By Application
By Product
By End User
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region